6/27/2013

The health care sector in India has tripled in the past 10 years, but it still faces substantial problems revolving around infrastructure, regulation, clinical trials and intellectual property, according to a report commissioned by the USA-India Chamber of Commerce. "The findings should help senior management of biopharma companies fine tune their R&D strategy and help leverage India's pockets of R&D strengths," said the group's president, Karun Rishi.

Full Story:
BioSpectrum Asia

Related Summaries